Skip to content
    DaVita Venture Group logo

    DaVita Venture Group

    Denver, Colorado, United StatesFounded 2020
    davitaventuregroup.com/homepageLinkedIn
    HealthcareBiotech & Life Sciences

    DaVita Venture Group focuses on making minority investments in early and later-stage companies within the healthcare devices, healthcare services, pharmaceuticals, and digital health sectors. Their strategy is to accelerate advancements in kidney care and related chronic conditions by identifying strategic partnerships, venture investment opportunities, and incubating transformative solutions to improve patient health and quality of life.

    60% of their portfolio is in Healthcare. They made 2 investments in the last 12 months. Their most common stage is series-a (40% of deals). Average disclosed round size is $63.6M (across 4 rounds with reported amounts).

    Find people at DaVita Venture Group on Goldilocks AI

    Portfolio

    5

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    2

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    5 investments
    CompanyRoundAmountDate
    R1 Therapeutics logoR1 TherapeuticsSeries A$77.5MMar 2026
    EElara CaringUnknown—Feb 2026
    Pathalys Pharma, Inc. logoPathalys Pharma, Inc.Growth$150MJan 2023
    ConsejoSano logoConsejoSanoSeries B$17MDec 2020
    Wellth logoWellthSeries A$10MMay 2020

    Top Co-Investors

    Abingworth2 shared
    The Carlyle Group1 shared
    OrbiMed1 shared
    Catalys Pacific1 shared
    F-Prime Capital1 shared
    SymBiosis1 shared
    Yabeo1 shared
    Boehringer Ingelheim Venture Fund1 shared
    AXA Venture Partners1 shared
    NF Ventures1 shared
    Partnership Fund for New York City1 shared
    I2BF1 shared
    Rock Health1 shared
    Salesforce1 shared
    7wireVentures1 shared
    Impact Engine1 shared
    Magnetic1 shared

    Last updated: 9 April 2026